Kevin Caliendo
Stock Analyst at UBS
(4.15)
# 480
Out of 5,090 analysts
202
Total ratings
67.96%
Success rate
7.93%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Maintains: Neutral | $77 → $79 | $85.26 | -7.34% | 2 | Nov 10, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $6.46 | +54.92% | 6 | Nov 7, 2025 | |
| COR Cencora | Maintains: Buy | $380 → $415 | $337.63 | +22.92% | 4 | Nov 7, 2025 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $4.25 → $4 | $2.75 | +45.35% | 7 | Nov 6, 2025 | |
| MCK McKesson | Maintains: Buy | $920 → $980 | $814.18 | +20.37% | 17 | Nov 6, 2025 | |
| OMI Owens & Minor | Downgrades: Neutral | $7 → $4 | $2.55 | +56.86% | 7 | Nov 3, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $185 → $220 | $199.19 | +10.45% | 18 | Oct 31, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $17 → $18 | $19.37 | -7.05% | 8 | Oct 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $378 → $430 | $333.49 | +28.94% | 13 | Oct 29, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $325 → $320 | $261.48 | +22.38% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $23 | $11.27 | +104.17% | 12 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $150.57 | +12.90% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $96 | $76.75 | +25.08% | 10 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $184.18 | +3.16% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $160 → $155 | $156.38 | -0.88% | 19 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $70 | $73.13 | -4.28% | 6 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $18 → $22 | $20.13 | +9.29% | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $4.01 | +274.06% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $4.12 | +118.45% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $268.42 | +45.29% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $253.02 | -1.19% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $38.85 | +103.35% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $333.49 | +72.42% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $202.48 | -11.10% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $7.78 | +825.45% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $28.41 | -61.28% | 4 | May 4, 2021 |
Solventum
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $85.26
Upside: -7.34%
LifeStance Health Group
Nov 7, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $6.46
Upside: +54.92%
Cencora
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $337.63
Upside: +22.92%
GoodRx Holdings
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.75
Upside: +45.35%
McKesson
Nov 6, 2025
Maintains: Buy
Price Target: $920 → $980
Current: $814.18
Upside: +20.37%
Owens & Minor
Nov 3, 2025
Downgrades: Neutral
Price Target: $7 → $4
Current: $2.55
Upside: +56.86%
Cardinal Health
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $199.19
Upside: +10.45%
Alignment Healthcare
Oct 31, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $19.37
Upside: -7.05%
UnitedHealth Group
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $333.49
Upside: +28.94%
Labcorp Holdings
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $261.48
Upside: +22.38%
Oct 28, 2025
Maintains: Buy
Price Target: $24 → $23
Current: $11.27
Upside: +104.17%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $150.57
Upside: +12.90%
Oct 24, 2025
Maintains: Buy
Price Target: $79 → $96
Current: $76.75
Upside: +25.08%
Oct 17, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $184.18
Upside: +3.16%
Oct 16, 2025
Maintains: Neutral
Price Target: $160 → $155
Current: $156.38
Upside: -0.88%
Aug 6, 2025
Maintains: Neutral
Price Target: $75 → $70
Current: $73.13
Upside: -4.28%
Jul 29, 2025
Maintains: Neutral
Price Target: $18 → $22
Current: $20.13
Upside: +9.29%
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $4.01
Upside: +274.06%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $4.12
Upside: +118.45%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $268.42
Upside: +45.29%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $253.02
Upside: -1.19%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $38.85
Upside: +103.35%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $333.49
Upside: +72.42%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $202.48
Upside: -11.10%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $7.78
Upside: +825.45%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $28.41
Upside: -61.28%